Compare OLLI & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLLI | CYTK |
|---|---|---|
| Founded | 1982 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.0B |
| IPO Year | 2015 | 2004 |
| Metric | OLLI | CYTK |
|---|---|---|
| Price | $113.55 | $65.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 17 |
| Target Price | ★ $140.69 | $85.24 |
| AVG Volume (30 Days) | 1.0M | ★ 1.6M |
| Earning Date | 03-18-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.35 | N/A |
| EPS | ★ 3.61 | N/A |
| Revenue | ★ $2,537,026,000.00 | $87,211,000.00 |
| Revenue This Year | $19.12 | $341.94 |
| Revenue Next Year | $13.16 | $50.15 |
| P/E Ratio | $31.50 | ★ N/A |
| Revenue Growth | 12.58 | ★ 2609.26 |
| 52 Week Low | $94.88 | $29.31 |
| 52 Week High | $141.74 | $70.98 |
| Indicator | OLLI | CYTK |
|---|---|---|
| Relative Strength Index (RSI) | 52.40 | 55.74 |
| Support Level | $106.52 | $60.05 |
| Resistance Level | $117.01 | $67.89 |
| Average True Range (ATR) | 3.45 | 2.78 |
| MACD | 0.63 | 0.24 |
| Stochastic Oscillator | 73.20 | 79.26 |
Ollie's Bargain Outlet Holdings Inc is a retailer of closeout merchandise and excess inventory. The company sells name brand household related items that consumers use in their everyday lives at prices that are heavily discounted below traditional retailers. It offers customers a broad selection of brand name products, including housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns.
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.